MorphoSys (MOR) News Today

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

$18.05

+0.01 (+0.06%)

(As of 04/18/2024 ET)

Source

Source	Headline
	MorphoSys AG (NASDAQ:MOR) Short Interest Down 22.0% in March marketbeat.com - April 13 at 1:31 PM
	EQS-News: MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis markets.businessinsider.com - April 11 at 9:31 AM
	MorphoSys Recommends Shareholders Accept Offer By Novartis - Quick Facts markets.businessinsider.com - April 11 at 9:31 AM
	MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis finance.yahoo.com - April 11 at 9:31 AM
	MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis businesswire.com - April 11 at 8:39 AM
	Aspermont Limited: Aspermont is Announcing 'Future of Mining Perth': Unveiling Innovations, Sustainability, and Industry Growth! finanznachrichten.de - April 11 at 8:12 AM
	Novartis begins tender offer for MorphoSys reuters.com - April 11 at 4:57 AM
	Novartis tender offer for MorphoSys AG commences globenewswire.com - April 11 at 4:20 AM
	MorphoSys AG (NASDAQ:MOR) Receives Consensus Rating of "Hold" from Analysts marketbeat.com - March 26 at 5:01 AM
	MorphoSys AG ADR (MOR) investing.com - March 20 at 10:36 PM
	MorphoSys AG (MOR) Q4 2023 Earnings Call Transcript seekingalpha.com - March 16 at 2:09 PM
	Earnings call: MorphoSys reported a strong performance for 2023 uk.investing.com - March 16 at 2:09 PM
	NVS Apr 2024 80.000 call ca.finance.yahoo.com - March 16 at 9:08 AM
	Hudson Bay Capital Management LP Reduces Position in MorphoSys AG (NASDAQ:MOR) marketbeat.com - March 16 at 5:44 AM
	Buy Rating Affirmed for Exact Sciences Amid Market Expansion and Product Advancement Prospects markets.businessinsider.com - March 15 at 3:08 PM
	MorphoSys' (MOR) "Equal Weight" Rating Reiterated at Wells Fargo & Company marketbeat.com - March 14 at 4:39 PM
	Biotech Rally Gets $100 Billion M&A Lift With More Deals to Come msn.com - March 14 at 8:28 AM
	MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update businesswire.com - March 13 at 4:02 PM
	EltaMD Establishes March 13th as National Dermatologist Day, Building a Healthier Future for All finance.yahoo.com - March 13 at 10:01 AM
	Here's what Wall Street expects from Morphosys's earnings markets.businessinsider.com - March 12 at 1:54 PM
	Here's what Wall Street expects from MorphoSys's earnings report markets.businessinsider.com - March 12 at 1:54 PM
	German competition regulator clears path for Novartis takeover of MorphoSys reuters.com - March 12 at 1:54 PM
	MorphoSys (NASDAQ:MOR) Sets New 12-Month High at $18.05 marketbeat.com - March 12 at 10:40 AM
	The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys finance.yahoo.com - March 11 at 1:14 PM
	MorphoSys (MOR) Set to Announce Quarterly Earnings on Wednesday marketbeat.com - March 6 at 9:14 AM
	Optiver Holding B.V. Acquires 142,382 Shares of MorphoSys AG (NASDAQ:MOR) marketbeat.com - February 23 at 10:22 AM
	MorphoSys (NASDAQ:MOR) Shares Gap Up to $16.27 marketbeat.com - February 7 at 12:45 PM
	Decoding MorphoSys's Options Activity: What's the Big Picture? benzinga.com - February 6 at 8:53 PM
	MorphoSys Shares Jump After It Agrees to $2.9 Billion Takeover by Novartis morningstar.com - February 6 at 8:53 PM
	MorphoSys (NASDAQ:MOR) Stock Price Down 6% marketbeat.com - February 6 at 2:25 PM
	MorphoSys Shares Jump After It Agrees to $2.9 Bln Takeover by Novartis marketwatch.com - February 6 at 12:39 PM
	MorphoSys drops amid speculation Novartis could walk from deal msn.com - February 6 at 12:39 PM
	Novartis Buys MorphoSys for €2.7 Billion to Get Cancer Drugs finance.yahoo.com - February 6 at 7:39 AM
	Novartis to bolster its oncology portfolio with acquisition of MorphoSys msn.com - February 5 at 11:22 PM
	MorphoSys Agrees To Be Acquired By Novartis For EUR 2.7 Bln markets.businessinsider.com - February 5 at 9:38 PM
	Novartis to acquire cancer drug developer MorphoSys for $2.9 billion msn.com - February 5 at 9:38 PM
	Novartis in the lead to acquire cancer drug developer MorphoSys, sources say cnbc.com - February 5 at 9:38 PM
	Novartis acquires cancer drug developer MorphoSys for $2.9 billion news.yahoo.com - February 5 at 6:22 PM
	EQS-News: MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value markets.businessinsider.com - February 5 at 6:22 PM
	Novartis acquires cancer drug developer MorphoSys for $2.9 bln reuters.com - February 5 at 6:22 PM
	Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1st Half morningstar.com - February 5 at 6:22 PM
	Incyte buys global rights for tafasitamab from MorphoSys msn.com - February 5 at 6:22 PM
	MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value finance.yahoo.com - February 5 at 6:22 PM
	Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1H finance.yahoo.com - February 5 at 6:22 PM
	Wells Fargo & Company Reaffirms Overweight Rating for MorphoSys (NASDAQ:MOR) marketbeat.com - February 5 at 3:41 PM
	MorphoSys (NASDAQ:MOR) Sees Strong Trading Volume marketbeat.com - February 5 at 1:58 PM
	Exclusive: Novartis in the lead to acquire cancer drug developer MorphoSys-sources reuters.com - February 5 at 11:37 AM
	marketbeat.com - February 5 at 10:22 AM
	MorphoSys AG (NASDAQ:MOR) Given Average Recommendation of "Moderate Buy" by Analysts marketbeat.com - February 5 at 3:20 AM
	MorphoSys (NASDAQ:MOR) Hits New 1-Year High at $11.80 marketbeat.com - February 2 at 1:15 PM

Get MorphoSys News Delivered to You Automatically

You’re invited: Biggest crypto event of 2024 (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

MOR Media Mentions By Week

MOR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MOR
News Sentiment
▼
0.59

0.53
▲
Average
Medical
News Sentiment

MOR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MOR Articles
This Week
▼
1

2
▲
MOR Articles
Average Week

Get MorphoSys News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:MOR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MorphoSys (MOR) News Today

MOR Media Mentions By Week

MOR Media Sentiment

MOR News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info